Bosentan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2924 publications

Assessing drug-induced liver injury liabilities in human and animal hepatocytes under static and perfused spheroid culture conditions.

Assessing drug-induced liver injury liabilities in human and animal hepatocytes under static and perfused spheroid culture conditions.

Journal: Toxicological sciences : an official journal of the Society of Toxicology

Published: September 04, 2026

Targeting Novel Pathways in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of New Therapeutic Agents.

Targeting Novel Pathways in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of New Therapeutic Agents.

Journal: Nigerian medical journal : journal of the Nigeria Medical Association

Published: September 01, 2026

Improvement of Refractory Cutaneous Ulcers and Pulmonary Arterial Hypertension Following Rituximab and Mycophenolate Mofetil Therapy in Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5) Antibody-Positive Dermatomyositis.

Improvement of Refractory Cutaneous Ulcers and Pulmonary Arterial Hypertension Following Rituximab and Mycophenolate Mofetil Therapy in Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5) Antibody-Positive Dermatomyositis.

Journal: Cureus

Published: July 01, 2026

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

Journal: Canadian journal of physiology and pharmacology

Published: June 30, 2026

Recurrent Seizure-Like Events in a Toddler With BMPR2-Related Pulmonary Arterial Hypertension.

Recurrent Seizure-Like Events in a Toddler With BMPR2-Related Pulmonary Arterial Hypertension.

Journal: Ochsner journal

Published: June 18, 2026

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis.

Hypotensive Events Associated With PDE-5 Inhibitors in Pulmonary Arterial Hypertension: Assessment of the USFDA Adverse Event Reporting System Using Disproportionality and Interaction Analysis.

Journal: Hospital pharmacy

Published: May 22, 2026

A targeted lipidomics workflow for high-throughput phenotyping and mechanism-based in vitro hepatotoxicity studies.

A targeted lipidomics workflow for high-throughput phenotyping and mechanism-based in vitro hepatotoxicity studies.

Journal: Toxicology in vitro : an international journal published in association with BIBRA

Published: May 18, 2026

Role for endothelin-1 in cardiometabolic dysfunction with intermittent hypoxia.

Role for endothelin-1 in cardiometabolic dysfunction with intermittent hypoxia.

Journal: Function (Oxford, England)

Published: May 18, 2026

Current status and evolution of targeted therapy for pulmonary arterial hypertension in China

Current status and evolution of targeted therapy for pulmonary arterial hypertension in China

Journal: Zhonghua yi xue za zhi

Published: May 14, 2026

L-carnosine as a biocompatible dipeptide carrier for oral delivery of amorphous bosentan: the ternary systems loaded with a new grade of poly(acrylic acid), hypromellose or copovidone.

L-carnosine as a biocompatible dipeptide carrier for oral delivery of amorphous bosentan: the ternary systems loaded with a new grade of poly(acrylic acid), hypromellose or copovidone.

Journal: International journal of pharmaceutics

Published: May 07, 2026

Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids-Application to recent real-world cases.

Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids-Application to recent real-world cases.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: April 22, 2026

Prophylactic Effects of Combined Bosentan and Nintedanib on Early Post-Traumatic Joint Contracture Formation in a Rat Model.

Prophylactic Effects of Combined Bosentan and Nintedanib on Early Post-Traumatic Joint Contracture Formation in a Rat Model.

Journal: Journal of clinical medicine

Published: April 21, 2026

Showing 1-12 of 2,924

Last Updated: 09/26/2026